These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 19767787)

  • 1. Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.
    Kennedy GA; Kearey N; Bleakley S; Butler J; Mudie K; Durrant S
    Bone Marrow Transplant; 2010 Apr; 45(4):699-704. PubMed ID: 19767787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.
    Willems E; Baron F; Seidel L; Frère P; Fillet G; Beguin Y
    Bone Marrow Transplant; 2010 Apr; 45(4):689-93. PubMed ID: 19718063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.
    Mulay S; Kreuter JD; Bryant SC; Elliott MA; Hogan WJ; Winters JL; Gastineau DA
    J Clin Apher; 2015 Jun; 30(3):147-53. PubMed ID: 25230249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
    Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.
    Laskin BL; Goebel J; Davies SM; Khoury JC; Bleesing JJ; Mehta PA; Filipovich AH; Paff ZN; Lawrence JM; Yin HJ; Pinkard SL; Jodele S
    Bone Marrow Transplant; 2011 May; 46(5):682-9. PubMed ID: 20697372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
    Oran B; Donato M; Aleman A; Hosing C; Korbling M; Detry MA; Wei C; Anderlini P; Popat U; Shpall E; Giralt S; Champlin RE
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):469-77. PubMed ID: 17382253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim Y; Kim DW; Lee JW; Min WS; Kim CC
    Bone Marrow Transplant; 2008 May; 41(9):813-20. PubMed ID: 18209725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 9 patients with transplant-related thrombotic microangiopathy].
    Zhang BL; Zhou J; Gui RR; Zu YL; Zhang YL; Song YP
    Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):423-427. PubMed ID: 31159520
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.
    Cho BS; Yahng SA; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
    Transplantation; 2010 Oct; 90(8):918-26. PubMed ID: 20717073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation.
    Mii A; Shimizu A; Masuda Y; Fujino T; Kaneko T; Utsumi K; Arai T; Ishikawa A; Wakamatsu K; Tajika K; Iino Y; Katayama Y; Fukuda Y
    Pathol Int; 2011 Jan; 61(1):34-41. PubMed ID: 21166941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.
    Elsallabi O; Bhatt VR; Dhakal P; Foster KW; Tendulkar KK
    Clin Appl Thromb Hemost; 2016 Jan; 22(1):12-20. PubMed ID: 26239316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Mii A; Shimizu A; Kaneko T; Fujita E; Fukui M; Fujino T; Utsumi K; Yamaguchi H; Tajika K; Tsuchiya S; Iino Y; Katayama Y; Fukuda Y
    Pathol Int; 2011 Sep; 61(9):518-27. PubMed ID: 21884301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic microangiopathy in transplantation and malignancy.
    Qu L; Kiss JE
    Semin Thromb Hemost; 2005 Dec; 31(6):691-9. PubMed ID: 16388420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
    Cutler C; Henry NL; Magee C; Li S; Kim HT; Alyea E; Ho V; Lee SJ; Soiffer R; Antin JH
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):551-7. PubMed ID: 15983555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?
    Llamas P; Romero R; Cabrera R; Sanjuán I; Forés R; Fernández MN
    Bone Marrow Transplant; 1997 Aug; 20(4):305-6. PubMed ID: 9285545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.
    Arai Y; Yamashita K; Mizugishi K; Watanabe T; Sakamoto S; Kitano T; Kondo T; Kawabata H; Kadowaki N; Takaori-Kondo A
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1683-9. PubMed ID: 24055655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
    Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M
    Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
    Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
    Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
    Uderzo C; Bonanomi S; Busca A; Renoldi M; Ferrari P; Iacobelli M; Morreale G; Lanino E; Annaloro C; Volpe AD; Alessandrino P; Longoni D; Locatelli F; Sangalli H; Rovelli A
    Transplantation; 2006 Sep; 82(5):638-44. PubMed ID: 16969286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.